Rare Disease Biotech Offers Access Ahead of Key Milestone

This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.

Newmont Corp
NYSE:NEM
$86.19
Open 86.89 Prev Close 85.95
High 86.93 Low 83.27
Volume 9,055,904 Volume (Avg) 11,195
52 Week High 87.93 52 Week Low 36.35
Market Cap 94.7B PE Ratio 15.47

General

NameNewmont Corp
TickerNEM
ExchangeNYSE
SectorBasic Materials
IndustryGold
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees22,200

About Newmont Corp

Newmont Corporation engages in the production and exploration of gold properties. It also explores for copper, silver, zinc, lead, and other metals. The company has operations and/or assets in the United States, Canada, Mexico, Dominican Republic, Peru, Suriname, Argentina, Chile, Australia, Papua New Guinea, Ecuador, Fiji, and Ghana, and internationally. Newmont Corporation was founded in 1916 and is headquartered in Denver, Colorado.

Highlights

Analyst Target86.32
Market Cap94,671,000,000
PE Ratio15.47
PEG Ratio2.76
EBITDA10,938,000,384

Valuation

Trailing PE15.57
Forward PE15.43
Price/Sales (Trailing 12 Mt.)4.64
Price/Book (Most Recent Quarter)2.88

Technicals

Beta0.35
52 Week High87.93
52 Week Low36.35
50 Day Average16.96%
200 Day Average56.16%

Dividend

Newmont Corp pays out a dividend of $0.92 per share, with a dividend yield of 1.06%.

NEM's last dividend payment was made to shareholders on September 29, 2025.

They pay out 35.00% of their earnings out as a dividend.

Recent Dividends

Sep 29, 2025$0.25
Jun 20, 2025$0.25
Mar 27, 2025$0.25
Dec 23, 2024$0.25
Sep 30, 2024$0.25
Jun 27, 2024$0.25
Mar 28, 2024$0.25
Dec 22, 2023$0.40
Most Popular

Nvidia's Value Reaches $4.6 Trillion, Bitcoin Eyes $120,000: What's Moving Markets Thursday?

On the second day of the U.S. government shutdown, Wall Street remains largely subdued, with indexes showing only slight midday declines after touching fresh record highs at the open.

Trump administration cuts nearly $8B in clean energy projects in blue states

WASHINGTON (AP) — The Trump administration is cancelling $7.6 billion in grants that supported hundreds of clean energy projects in 16 states, all of which voted for Democrat Kamala Harris in last year's presidential election.

Gold Is Being Reintroduced Into the Monetary System - Ad

While the media focuses on political scandals, inflation and coming up with ridiculous acronyms "TACO"... Smart money is tracking a far bigger shift: a gold revaluation is quietly underway. Garrett Goggin, CFA, says this could trigger 100X moves in select miners - and he's identified four with the biggest upside.

Two Delta jets damaged in 'low-speed collision' on LaGuardia taxiway, injuring 1

Two Delta Air Lines regional jets collided on the taxiway at LaGuardia Airport in New York, injuring a flight attendant, damaging a cockpit and tearing off part of a wing in what the airline described as a “low-speed collision.”

Palantir Stock Climbs Nearly 2% In Thursday Pre-Market: What's Going On?

Shares of Palantir Technologies Inc. (NASDAQ: PLTR) climbed 1.53% in Thursday pre-market after it signed a strategic deal worth billions with the U.K. government.

[Revealed] Trump's Next AI Executive Orders? - Ad

A White House insider with direct ties to Trump's inner circle just revealed what he calls "Manhattan II" - a potential $2.2 trillion AI initiative set to launch as soon as Oct 15. He says this could mirror past U.S. projects that minted fortunes - with small firms soaring 5,000% to 10,000% over two decades. And now he's giving away his #1 stock pick for free before the deadline.

Cathie Wood Dumps $5.2 Million Worth of This AI Stock, Here's What Ark Bought Instead

Ark Invest decided to sell shares of Tempus AI (TEM), despite positive news of FDA clearance for its diagnostic device. They also made other key trades.

Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

What to know about Brendan Carr, the head of the Federal Communications Commission

WASHINGTON (AP) — ABC took comic Jimmy Kimmel's off the air indefinitely Wednesday, just hours after Federal Communications Commission chairman Brendan Carr called his comments about Charlie Kirk's assassination “truly sick.”

Airbnb's Brian Chesky Agrees That Current AI Is 'Overrated,' Predicts 'Sudden' Changes Next Decade

Airbnb CEO Brian Chesky expressed his belief that daily life will remain relatively unchanged by artificial intelligence (AI) in the coming decade. However, he predicts a significant shift in the following decade.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Another Gold High? Here's the Move Wall Street Is Missing ... - Ad

Gold just surged past $3,600, up 45% in a year - but Sean Brodrick says $6,900 could be next. History shows when gold booms, one hidden play has delivered far bigger gains - 21x, 49x, even 1,386x. The same strategy once handed 26,000% profits. And Sean says it's back on the table now.

BlackRock Turns Popular Mutual Funds Into Global Equity ETFs

BlackRock turns two top mutual funds into active ETFs, giving investors global equity exposure and strategies to manage volatility.

It's 'do or die' for electric vehicle maker Rivian as it breaks ground on a $5 billion plant

ATLANTA (AP) — It seems like a terrible time to build an electric vehicle plant in the United States, but Rivian Automotive leaders say they're confident as the company starts on a $5 billion facility in Georgia.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

Jay-Z-backed plan for Times Square casino loses bid for NYC license amid Broadway opposition

NEW YORK (AP) — A proposed Caesars Palace casino in Times Square that’s backed by Jay-Z lost its bid for a lucrative on Wednesday after running into fierce opposition from Broadway theater owners and producers who were worried about its potential impact on the theater district.

New Biotech Offering Targets $426B Rare Disease Market - Ad

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

Lam Research And JSR Resolve Legal Disputes As They Team Up On AI Era Chips

Lam Research and JSR Corp agreed to collaborate and cross-license, combining their expertise to accelerate semiconductor manufacturing and reduce costs.

The "Mar-A-Lago Accord" Is Now Underway - Ad

The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)

Australia warns social media platforms against age verification for all ahead of a ban on children

MELBOURNE, Australia (AP) — Australian authorities said Tuesday that should not demand age verification for all account holders starting from December, when a having accounts goes into effect in the country.

Nvidia Is About to Shock the World: October 23rd - Ad

Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%, is warning everyone to... Mark this date on your calendar: October 23rd! That's when Nvidia could help send shares of this Elon Musk supplier skyrocketing higher.

US orders Delta and Aeromexico to dissolve their partnership over fairness concerns in Mexico

U.S. Transportation Secretary Sean Duffy is following through on to force Delta and Aeromexico to dissolve their longtime partnership because of his concerns that Mexico isn't being fair to U.S. airlines.

Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad

This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.

Appeals court rejects Trump's bid to unseat Federal Reserve governor Lisa Cook ahead of rate vote

WASHINGTON (AP) — An appeals court ruled Monday that can remain a Federal Reserve governor, rebuffing President Donald Trump’s efforts to remove her just ahead of a key vote on interest rates.

Ethereum Co-Founder Vitalik Buterin Responds to Security Concerns Over OpenAI's ChatGPT

Ethereum co-founder Vitalik Buterin has voiced his concerns over potential security risks associated with OpenAI's ChatGPT, which could lead to the leakage of personal user data.

Gold Is Being Reintroduced Into the Monetary System - Ad

While the media focuses on political scandals, inflation and coming up with ridiculous acronyms "TACO"... Smart money is tracking a far bigger shift: a gold revaluation is quietly underway. Garrett Goggin, CFA, says this could trigger 100X moves in select miners - and he's identified four with the biggest upside.

A United Airlines passenger plane makes emergency landing in Osaka as cargo fire is suspected

NAGASAKI, Japan (AP) — A United Airlines passenger plane carrying 142 people and bound for the Philippine island of Cebu made an emergency landing in Osaka on Friday after an indicator showed a fire in the cargo room, Japanese aviation officials said.

Opendoor Stock Rallies On Expansion And Short Squeeze Hopes

Opendoor stock rallied on Wednesday after it announced an expansion of U.S. operations, but it didn't specify which operations.

[Revealed] Trump's Next AI Executive Orders? - Ad

A White House insider with direct ties to Trump's inner circle just revealed what he calls "Manhattan II" - a potential $2.2 trillion AI initiative set to launch as soon as Oct 15. He says this could mirror past U.S. projects that minted fortunes - with small firms soaring 5,000% to 10,000% over two decades. And now he's giving away his #1 stock pick for free before the deadline.

Benzinga Bulls And Bears: Oracle, Micron, Land's End — And Ellison Briefly Bests Musk

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

Elizabeth Warren Says Measles Can Hit Record Highs, Slams RFK Jr.'s CDC Panel For Delaying Vaccine: 'How Does That Keep Our Kids Safe?'

Sen. Elizabeth Warren (D-Mass.) on Thursday criticized the Centers for Disease Control and Prevention's vaccine advisory panel following its controversial vote to delay the combined measles, mumps, rubella, and varicella or MMRV vaccine for children under 4 years old.

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright markethundred.com
Privacy Policy | Terms of Service